isomethyleugenol has been researched along with Idiopathic Parkinson Disease in 58 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (27.59) | 18.7374 |
| 1990's | 18 (31.03) | 18.2507 |
| 2000's | 12 (20.69) | 29.6817 |
| 2010's | 9 (15.52) | 24.3611 |
| 2020's | 3 (5.17) | 2.80 |
| Authors | Studies |
|---|---|
| Francis, P; Geut, H; Hannon, E; Henriksen, SP; Love, S; Mill, J; Pihlstrøm, L; Rozemuller, AJM; Shireby, G; Thomas, AJ; Toft, M; Tunold, JA; van de Berg, WDJ | 1 |
| Iga, JI; Nagai, M; Nomoto, M; Ochi, S; Ozaki, Y; Ueno, SI; Yamazaki, K; Yoshino, Y | 1 |
| Basavarajappa, BS; Subbanna, S | 1 |
| Neal, M; Richardson, JR | 1 |
| Burbulla, LF; Jeon, S; Jiang, W; Krainc, D; Oevel, K; Silverman, RB; Ysselstein, D; Zheng, J | 1 |
| Ali, S; Chen, X; Guo, M; Huang, H; Huang, Y; Qie, S; Wang, J; Wang, S; Yu, C; Zhang, L; Zheng, X | 1 |
| Chen, C; Guo, J; Min, S; Pan, H; Qin, L; Shu, L; Sun, Q; Tang, B; Xu, Q; Yan, X; Zhong, J | 1 |
| Jadavji, NM; Murray, LK | 1 |
| Monti, B; Peña-Altamira, LE; Polazzi, E | 1 |
| Bolt, EL; Carter, WG; Cass, S; Ray, DE; Vigneswara, V; Wayne, D | 1 |
| Calzada, E; Claypool, SM; Onguka, O | 1 |
| Bouchard, TP; Camicioli, RM; Somerville, MJ | 1 |
| Dillmann, U; Fassbender, K; Herrmann, W; Kostopoulos, P; Obeid, R; Schadt, A | 1 |
| Barone, P; De Bonis, ML; Galletti, P; Ingrosso, D; Longo, K; Pellecchia, MT; Russo, A; Salvatore, A; Tedeschi, G; Tessitore, A; Zappia, V | 1 |
| Mattson, MP; Shea, TB | 1 |
| Decker, PA; Dousa, MK; Muenter, MD; Offord, KP; Tyce, GM; Weinshilboum, RM | 1 |
| Steventon, GB; Waring, RH; Williams, AC | 1 |
| Di Rocco, A; Werner, P | 1 |
| Brosnan, JT; Brosnan, ME; Jacobs, RL; Stead, LM | 1 |
| Ramsden, DB; Williams, AC | 2 |
| Awad, L; Benavides, J; Camelin, JC; Gauthier, A; Laquais, B; Lefur, G; Meininger, V; Mizoule, J; Phan, T; Uzan, A | 1 |
| Lewis, ME | 1 |
| Bottiglieri, T; Hyland, K; Reynolds, EH | 1 |
| Dostert, P; Maruyama, W; Matsubara, K; Naoi, M | 1 |
| Green, S; Peters, L; Steventon, GB; Sturman, S; Waring, RH; Williams, AC | 1 |
| Maruyama, W; Nagatsu, T; Naoi, M; Niwa, T | 1 |
| Cobuzzi, RJ; Collins, MA; Neafsey, EJ | 1 |
| Buttrum, S; Green, S; Molloy, H; Pall, HS; Steventon, GB; Waring, RH; Williams, AC | 1 |
| Dostert, P; Nagatsu, T; Naoi, M; Yoshida, M | 1 |
| Männistö, PT; Reenilä, I; Tuomainen, P | 1 |
| Charlton, CG; Crowell, B | 1 |
| Hattori, T; Kondo, T; Mizuno, Y; Nakagawa-Hattori, Y | 1 |
| Collins, MA; Gearhart, DA; Neafsey, EJ | 1 |
| Hoffman, RM | 1 |
| Häussermann, P; Kuhn, W; Müller, T; Przuntek, H; Rommelspacher, H; Sällström Baum, S; Woitalla, D | 1 |
| Aoyama, K; Fukushima, S; Hayase, N; Kobayashi, S; Matsubara, K; Ohta, S; Okada, K; Satomi, M; Shimizu, K; Shiono, H; Uezono, T; Yamaguchi, S | 1 |
| Steventon, GB; Sturman, S; Waring, RH; Williams, AC | 1 |
| Zhu, BT | 1 |
| Fremouw-Ottevangers, DC; Gerding, AM; Muskiet, FA; Nagel, GT; Thomasson, CG; Wolthers, BG | 1 |
| Muenter, MD; Sharpless, NS; Tyce, GM | 1 |
| Dostert, P; Maruyama, W; Nagatsu, T; Nakahara, D; Naoi, M; Niwa, T; Takahashi, A; Takeda, N; Tatematsu, A; Yoshizumi, H | 1 |
| Roth, JA | 1 |
| Albores, R; Cobuzzi, R; Collins, MA; Fields, J; Matsubara, K; Neafsey, EJ; Rollema, H | 1 |
| Buttrum, S; Green, S; Molloy, H; Pall, H; Steventon, G; Sturman, S; Waring, R; Williams, A | 1 |
| Steventon, G; Sturman, S; Waring, R; Williams, A | 1 |
| Costall, B; Jenner, P; Marsden, CD; Naylor, R; Testa, B | 1 |
| Hirose, S; Ishimitsu, T | 1 |
| Chase, TN; Woods, AC | 1 |
| Hartley, R; Smith, JA | 1 |
| Barrass, BC; Coult, DB; Pinder, RM | 1 |
| Ceccato, S; Passeri, M | 1 |
| Sandler, M | 1 |
| Brossi, A; Teitel, S | 1 |
| Bohuon, C; Comoy, E; Lhermitte, F; Rosa, A | 1 |
| Goodwin, FK | 1 |
| Cotzias, GC | 1 |
| Radouco-Thomas, S | 1 |
18 review(s) available for isomethyleugenol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Epigenome-wide association study of human frontal cortex identifies differential methylation in Lewy body pathology.
Topics: alpha-Synuclein; Epigenome; Frontal Lobe; Humans; Lewy Bodies; Lewy Body Disease; Methylation; Parkinson Disease | 2022 |
Histone Methylation Regulation in Neurodegenerative Disorders.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Epigenesis, Genetic; Histone Code; Histones; Humans; Huntington Disease; Methylation; Neurodegenerative Diseases; Parkinson Disease; Protein Processing, Post-Translational; Substance-Related Disorders | 2021 |
Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration.
Topics: Acetylation; Alzheimer Disease; Animals; Astrocytes; Cell Differentiation; DNA Methylation; Epigenesis, Genetic; Histones; Humans; Inflammation; Methylation; MicroRNAs; Neurodegenerative Diseases; Neuroglia; Neurons; Parkinson Disease | 2018 |
The role of one-carbon metabolism and homocysteine in Parkinson's disease onset, pathology and mechanisms.
Topics: Animals; Diet; Folic Acid; Genetic Predisposition to Disease; Homocysteine; Humans; Levodopa; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Nutritional Status; One-Carbon Group Transferases; Parkinson Disease; Polymorphism, Genetic; Vitamin B Complex | 2019 |
Histone post-translational modifications in Huntington's and Parkinson's diseases.
Topics: Animals; Brain; Disease Models, Animal; Histone Deacetylase Inhibitors; Histones; Humans; Huntington Disease; Methylation; Molecular Targeted Therapy; Nerve Tissue Proteins; Neurons; Parkinson Disease; Phosphorylation; Protein Processing, Post-Translational; Ubiquitination | 2013 |
Phosphatidylethanolamine Metabolism in Health and Disease.
Topics: Alzheimer Disease; Animals; Autophagy; Candida; Carboxy-Lyases; Cell Membrane; Cytidine Diphosphate; Ethanolamines; Humans; Lipid Metabolism; Methylation; Mitochondria; Non-alcoholic Fatty Liver Disease; Oxidative Phosphorylation; Parkinson Disease; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Prions; Protein Processing, Post-Translational; Virulence | 2016 |
Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders.
Topics: Aging; Alzheimer Disease; Animals; Apoptosis; Cell Death; Depressive Disorder; Folic Acid; Homocysteine; Humans; Mental Disorders; Methylation; Neurodegenerative Diseases; Neuronal Plasticity; Neurons; Parkinson Disease; Schizophrenia; Stroke | 2003 |
Methylation demand: a key determinant of homocysteine metabolism.
Topics: Animals; Creatine; Guanidinoacetate N-Methyltransferase; Homocysteine; Humans; Levodopa; Methylation; Methyltransferases; Models, Biological; Models, Chemical; Parkinson Disease; Phosphatidylcholines; Phosphatidylethanolamine N-Methyltransferase; Rats | 2004 |
Autotoxicity, methylation and a road to the prevention of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine Agents; Humans; Methylation; Niacinamide; Parkinson Disease; Parkinson Disease, Secondary; Risk Factors; S-Adenosylmethionine | 2005 |
Biochemical aspects of schizophrenia.
Topics: Amphetamines; Animals; Antipsychotic Agents; Brain; Catecholamines; Dopamine; Humans; Indoles; Mesencephalon; Methionine; Methylation; Monoamine Oxidase; Norepinephrine; Parkinson Disease; Receptors, Dopamine; Schizophrenia | 1980 |
The clinical potential of ademetionine (S-adenosylmethionine) in neurological disorders.
Topics: AIDS Dementia Complex; Animals; Brain Diseases; Dementia; Disease Models, Animal; Epilepsy; Humans; Metabolism, Inborn Errors; Methotrexate; Methylation; Multiple Sclerosis; Neurotransmitter Agents; Parkinson Disease; Receptors, Neurotransmitter; S-Adenosylmethionine; Spinal Cord Diseases | 1994 |
Methioninase: a therapeutic for diseases related to altered methionine metabolism and transmethylation: cancer, heart disease, obesity, aging, and Parkinson's disease.
Topics: Aging; Animals; Carbon-Sulfur Lyases; Drug Interactions; Drug Therapy, Combination; Heart Diseases; Humans; Methionine; Methylation; Neoplasms; Obesity; Parkinson Disease; Recombinant Proteins | 1997 |
A review of xenobiotic metabolism enzymes in Parkinson's disease and motor neuron disease.
Topics: Adult; Aged; Carbocysteine; Case-Control Studies; Expectorants; Humans; Methylation; Methyltransferases; Middle Aged; Monoamine Oxidase; Motor Neuron Disease; Odds Ratio; Oxidation-Reduction; Parkinson Disease; Phenotype; Statistics, Nonparametric; Substrate Specificity; Xenobiotics | 2001 |
Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis.
Topics: Animals; Catechol O-Methyltransferase; Catecholamines; Catechols; Dopamine; Enzyme Inhibitors; Estrogens; Humans; Kinetics; Methylation; Neoplasms; Parkinson Disease; Plant Preparations; Polymorphism, Genetic; Xenobiotics | 2002 |
Membrane-bound catechol-O-methyltransferase: a reevaluation of its role in the O-methylation of the catecholamine neurotransmitters.
Topics: Animals; Antidepressive Agents; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Catecholamines; Cell Membrane; Gene Expression Regulation, Enzymologic; Humans; Membrane Proteins; Methylation; Parkinson Disease | 1992 |
L-dopa metabolism in man (with special reference to parkinsonism).
Topics: Catecholamines; Dihydroxyphenylalanine; Dopamine; Humans; Hydroxylation; Methylation; Norepinephrine; Parkinson Disease; Schiff Bases | 1972 |
Alkaloids in the mammalian system.
Topics: 5-Hydroxytryptophan; Acetaldehyde; Alkaloids; Animals; Aporphines; Biogenic Amines; Catalysis; Cells, Cultured; Circular Dichroism; Cyclization; Dealkylation; Dihydroxyphenylalanine; Humans; Isoquinolines; Magnetic Resonance Spectroscopy; Mammals; Methylation; Molecular Conformation; Parkinson Disease; Stereoisomerism; Tryptophan | 1974 |
Psychiatric side effects of levodopa in man.
Topics: Animals; Brain; Catecholamines; Cognition Disorders; Delirium; Depression; Dihydroxyphenylalanine; Dopamine; Female; Haplorhini; Humans; Hyperkinesis; Male; Methylation; Methyltyrosines; Parkinson Disease; Psychoses, Substance-Induced; Rats; Sexual Behavior; Time Factors | 1971 |
2 trial(s) available for isomethyleugenol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Plasma levels of R- and S-salsolinol are not increased in "de-novo" Parkinsonian patients.
Topics: Adult; Aged; Aged, 80 and over; Dopamine; Female; Humans; Isoquinolines; Male; Methylation; Middle Aged; Parkinson Disease; Stereoisomerism | 1998 |
N-methylation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test.
Topics: Aged; Aging; Aldehyde Oxidase; Aldehyde Oxidoreductases; Brain; Carbolines; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Female; Humans; Isoquinolines; Male; Methylation; Middle Aged; Niacinamide; Parkinson Disease | 2000 |
38 other study(ies) available for isomethyleugenol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
DRD2 methylation to differentiate dementia with Lewy bodies from Parkinson's disease.
Topics: Aged; Aged, 80 and over; Biomarkers; Diagnosis, Differential; Female; Humans; Leukocytes; Lewy Body Disease; Male; Methylation; Parkinson Disease; Receptors, Dopamine D2 | 2020 |
Conversion of Quinazoline Modulators from Inhibitors to Activators of β-Glucocerebrosidase.
Topics: Dopaminergic Neurons; Enzyme Activators; Enzyme Inhibitors; Gaucher Disease; Glucosylceramidase; Humans; Methylation; Parkinson Disease; Quinazolines; Structure-Activity Relationship | 2019 |
Down-Regulation of m6A mRNA Methylation Is Involved in Dopaminergic Neuronal Death.
Topics: Adenosine; Animals; Apoptosis; Brain; Cell Death; Disease Models, Animal; Dopaminergic Neurons; Down-Regulation; Epigenesis, Genetic; Male; Methylation; Oxidopamine; Parkinson Disease; PC12 Cells; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sympatholytics | 2019 |
Genetic analysis of DNA methylation and hydroxymethylation genes in Parkinson's disease.
Topics: DNA Methylation; Humans; Methylation; Parkinson Disease | 2019 |
Molecular ageing of alpha- and Beta-synucleins: protein damage and repair mechanisms.
Topics: alpha-Synuclein; Amino Acid Sequence; Animals; beta-Synuclein; Brain; Chromatography, Gel; Cytoplasm; Humans; Isoaspartic Acid; Isoelectric Point; Methylation; Mice; Mice, Knockout; Molecular Sequence Data; Mutation, Missense; Parkinson Disease; Protein D-Aspartate-L-Isoaspartate Methyltransferase; Protein Processing, Post-Translational; Sequence Homology, Amino Acid | 2013 |
Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson's disease patients.
Topics: Aged; Antiparkinson Agents; Cognition; Creatinine; Female; Folic Acid; Genotype; Homocysteine; Humans; Inactivation, Metabolic; Levodopa; Male; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Motor Skills; Neuropsychological Tests; Parkinson Disease; Severity of Illness Index; Vitamin B Complex | 2009 |
Methylation status and neurodegenerative markers in Parkinson disease.
Topics: Aged; alpha-Synuclein; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Biomarkers; Blood Platelets; Cognition Disorders; Female; Folic Acid; Homocysteine; Humans; Male; Methylation; Middle Aged; Nerve Degeneration; Parkinson Disease; Peptide Fragments; S-Adenosylhomocysteine; S-Adenosylmethionine; Substantia Nigra; Ultrasonography; Vitamin B 6 | 2009 |
Impaired transmethylation potential in Parkinson's disease patients treated with L-Dopa.
Topics: Aged; Antiparkinson Agents; Cross-Sectional Studies; Erythrocytes; Female; Genotype; Homocysteine; Humans; Levodopa; Male; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Parkinson Disease; Polymorphism, Genetic; S-Adenosylhomocysteine; S-Adenosylmethionine | 2010 |
L-DOPA biotransformation: correlations of dosage, erythrocyte catechol O-methyltransferase and platelet SULT1A3 activities with metabolic pathways in Parkinsonian patients.
Topics: Adenosine Diphosphate; Aged; Arylsulfotransferase; Biotransformation; Blood Platelets; Carbidopa; Catechol O-Methyltransferase; Dose-Response Relationship, Drug; Drug Combinations; Erythrocytes; Female; Humans; Levodopa; Male; Methylation; Middle Aged; Parkinson Disease; S-Adenosylmethionine; Sulfates | 2003 |
An investigation into the inter-relationships of sulphur xeno-biotransformation pathways in Parkinson's and motor neurone diseases.
Topics: Acetaminophen; Adult; Aged; Aged, 80 and over; Biotransformation; Carbocysteine; Erythrocytes; Female; Humans; Male; Methylation; Methyltransferases; Middle Aged; Motor Neuron Disease; Oxidation-Reduction; Parkinson Disease; Phenotype; Sulfur | 2003 |
Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status.
Topics: Antiparkinson Agents; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Methylation; Parkinson Disease; S-Adenosylmethionine; Vitamin B Complex | 2004 |
Nicotinamide homeostasis: a xenobiotic pathway that is key to development and degenerative diseases.
Topics: Animals; Choline; Embryonic Development; Epigenesis, Genetic; Evolution, Molecular; Homeostasis; Humans; Methylation; Models, Theoretical; Niacinamide; Parkinson Disease; Xenobiotics | 2005 |
[Methylation of erythrocyte membrane phospholipids: correlation with membrane viscosity. Study of normal and parkinsonian subjects].
Topics: Adolescent; Adult; Aged; Blood Viscosity; Erythrocyte Membrane; Female; Humans; Kinetics; Male; Membrane Fluidity; Membrane Lipids; Methylation; Middle Aged; Osmotic Fragility; Parkinson Disease; Phospholipids; Receptors, Neurotransmitter | 1984 |
N-methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity.
Topics: Animals; Ascorbic Acid; Catalase; Chromatography, High Pressure Liquid; Dopamine; Ferric Compounds; Ferrous Compounds; Free Radicals; Glutathione; Humans; Hydroxyl Radical; Isoquinolines; Methylation; Neurons; Oxidation-Reduction; Parkinson Disease; Salsoline Alkaloids; Superoxide Dismutase; Tetrahydroisoquinolines | 1995 |
D-penicillamine metabolism in neurodegenerative diseases: an in vivo/in vitro sulphydryl methylation study.
Topics: Adult; Aged; Aged, 80 and over; Erythrocyte Membrane; Female; Humans; Male; Methylation; Methyltransferases; Middle Aged; Motor Neuron Disease; Parkinson Disease; Penicillamine; Sulfhydryl Compounds | 1994 |
Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin.
Topics: Adenosine Triphosphate; Animals; Brain; Cell Count; Humans; Isoquinolines; Methylation; Microdialysis; Neurotoxins; Oxidation-Reduction; Parkinson Disease; PC12 Cells; Rats; Tissue Distribution | 1994 |
Differential cytotoxicities of N-methyl-beta-carbolinium analogues of MPP+ in PC12 cells: insights into potential neurotoxicants in Parkinson's disease.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cations; Cell Death; Culture Media; Energy Metabolism; Harmaline; Kinetics; L-Lactate Dehydrogenase; Methylation; Molecular Structure; Parkinson Disease; PC12 Cells; Rats | 1994 |
N-methylation of pyridines and Parkinson's disease.
Topics: Humans; Methylation; Methyltransferases; Niacinamide; Parkinson Disease; Pyridines; Pyridones | 1993 |
N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
Topics: Animals; Brain; Cell Death; Culture Techniques; Dopamine; Humans; Isoquinolines; Methylation; Methyltransferases; Monoamine Oxidase; Nerve Degeneration; Parkinson Disease; Rats; Receptors, Dopamine; Substantia Nigra; Tetrahydroisoquinolines | 1993 |
Validation of assay of catechol-O-methyltransferase activity in human erythrocytes.
Topics: Blood Proteins; Catechol O-Methyltransferase; Catechols; Chromatography, High Pressure Liquid; Electrochemistry; Enzyme Inhibitors; Enzyme Stability; Erythrocytes; Humans; Methylation; Nitriles; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity | 1996 |
Striatal dopamine depletion, tremors, and hypokinesia following the intracranial injection of S-adenosylmethionine: a possible role of hypermethylation in parkinsonism.
Topics: Animals; Antiparkinson Agents; Caudate Nucleus; Dopamine; Dose-Response Relationship, Drug; Hypokinesia; Injections, Intraventricular; Levodopa; Male; Methylation; Motor Activity; Neostriatum; Parkinson Disease; Rats; Rats, Sprague-Dawley; S-Adenosylhomocysteine; S-Adenosylmethionine; Tremor | 1995 |
S-methylation in Parkinson's disease.
Topics: Aged; Erythrocyte Membrane; Female; Humans; Male; Methylation; Methyltransferases; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Reference Values; Sulfhydryl Compounds | 1995 |
Characterization of brain beta-carboline-2-N-methyltransferase, an enzyme that may play a role in idiopathic Parkinson's disease.
Topics: Animals; Brain; Carbolines; Cattle; Cytosol; Enzyme Inhibitors; Harmine; Humans; Hydrogen-Ion Concentration; Kinetics; Methylation; Methyltransferases; Parkinson Disease; S-Adenosylhomocysteine; S-Adenosylmethionine; Zinc | 1997 |
Determination of catecholamines and their 3-O-methylated metabolites in urine by mass fragmentography with use of deuterated internal standards.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Age Factors; Aged; Catecholamines; Child; Child, Preschool; Deuterium; Dopamine; Epinephrine; Gas Chromatography-Mass Spectrometry; Humans; Infant; Infant, Newborn; Methylation; Middle Aged; Neuroblastoma; Norepinephrine; Parkinson Disease; Pheochromocytoma; Reference Values | 1979 |
Effect of L-DOPA on endogenous histamine metabolism.
Topics: Acetates; Adult; Aged; Animals; Carbidopa; Depression, Chemical; Female; Guinea Pigs; Histamine; Humans; Imidazoles; Levodopa; Male; Methylation; Middle Aged; Parkinson Disease; Rats; Species Specificity | 1975 |
Endogenous synthesis of N-methylsalsolinol, an analogue of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in rat brain during in vivo microdialysis with salsolinol, as demonstrated by gas chromatography-mass spectrometry.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Gas Chromatography-Mass Spectrometry; Isoquinolines; Male; Methylation; Parkinson Disease; Perfusion; Rats; Rats, Wistar; Salsoline Alkaloids; Tetrahydroisoquinolines | 1992 |
Indole-N-methylation of beta-carbolines: the brain's bioactivation route to toxins in Parkinson's disease?
Topics: Animals; Biotransformation; Brain; Carbolines; Humans; Methylation; Mitochondria; Neurotoxins; Parkinson Disease; Rats | 1992 |
N-methylation of pyridines in Parkinson's disease.
Topics: Humans; Methylation; Middle Aged; Niacinamide; Parkinson Disease | 1991 |
Xenobiotic enzyme profiles and Parkinson's disease.
Topics: Animals; Humans; Methylation; Methyltransferases; Monoamine Oxidase; MPTP Poisoning; Parkinson Disease; Sulfur; Xenobiotics | 1991 |
Does an endogenous methylpyridinium analogue cause Parkinson's disease?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Chemical Phenomena; Chemistry; Humans; Methylation; Parkinson Disease; Pyridines | 1985 |
Determination of m- and p-O-methylated products of L-3,4-dihydroxyphenylalanine using high-performance liquid chromatography and electrochemical detection.
Topics: Animals; Catechol O-Methyltransferase; Chromatography, High Pressure Liquid; Electrochemistry; Humans; Isomerism; Levodopa; Liver; Methylation; Parkinson Disease; Rats; Rats, Inbred Strains; Tyrosine | 1985 |
M.I.F.: effect on levodopa dyskinesias in man.
Topics: Antiparkinson Agents; Carbidopa; Carboxy-Lyases; Decarboxylation; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Humans; Melanocyte-Stimulating Hormones; Methylation; Movement Disorders; Parkinson Disease | 1973 |
Abnormal O-methylated dopamine metabolites: the endogenous toxins of schizophrenia or parkinsonism?
Topics: Animals; Behavior, Animal; Hallucinogens; Humans; Methylation; Parkinson Disease; Phenethylamines; Schizophrenia; Toxins, Biological | 1973 |
3-Hydroxy-4-methoxyphenethylamine: the endogenous toxin of parkinsonism?
Topics: Catechol O-Methyltransferase Inhibitors; Ceruloplasmin; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Humans; Methylation; Parkinson Disease; Phenethylamines; Protein Binding | 1972 |
[Significance of transmethylation and S-adenosylmethionine (SAM) in the management of Parkinson's disease with L-dopa].
Topics: Adenosine; Aged; Brain; Digestive System; Dihydroxyphenylalanine; Feeding and Eating Disorders; Female; Gastrointestinal Diseases; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney; Male; Methionine; Methylation; Nausea; Parkinson Disease; S-Adenosylmethionine; Vomiting | 1972 |
[Abnormal movements induced by L-Dopa and dopamine metabolism disorders].
Topics: Benzoates; Dihydroxyphenylalanine; Dopamine; Electrocoagulation; Female; Homovanillic Acid; Humans; Methylation; Middle Aged; Movement Disorders; Parkinson Disease | 1973 |
Levodopa in the treatment of Parkinsonism.
Topics: Animals; Apomorphine; Aromatic Amino Acid Decarboxylase Inhibitors; Brain; Dihydroxyphenylalanine; Dopamine; Esters; Humans; Hydrazines; Manganese Poisoning; Methylation; Methyldopa; Mice; Movement; Parkinson Disease; Parkinson Disease, Secondary; Phenylacetates | 1971 |
[Extrapyramidal syndrome in animal experiments: rôle of calcium and o-methylated derivatives].
Topics: Animals; Calcium; Calcium Metabolism Disorders; Depression, Chemical; Dihydroxyphenylalanine; Dopamine; Extrapyramidal Tracts; Guinea Pigs; Hydrogen-Ion Concentration; Methylation; Movement Disorders; Norepinephrine; Parkinson Disease; Pyrogallol; Rats; Reserpine; Serotonin Antagonists; Stimulation, Chemical; Synapses; Tranylcypromine | 1970 |